为基于CRISPR的基因组编辑提供自然启发的交付工具
Elizabeth Maria Clarissa1,2, Mamata Karmacharya1, Hyunmin Choi1,2
1Center for Algorithmic and Robotized Synthesis, Institute for Basic Science (IBS), UNIST-gil 50, Ulsan, 44919, Republic of Korea.
Small (Weinheim an der Bergstrasse, Germany)
|February 4, 2025
概括
有效和安全的传递系统对于聚类正规间隔短时间的Palindromic Repeats (CRISPR) 基因组编辑疗法至关重要. 纳米载体,包括病毒载体和细胞外囊泡,可以增强CRISPR.
科学领域:
- 生物技术和基因工程 生物技术和基因工程
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 克里斯普尔基因组编辑为遗传疾病提供了革命性的治疗潜力.
- 有效地传递CRISPR组件是临床翻译的一个主要挑战.
- 纳米载体系统正在成为有效和安全的CRISPR交付的关键解决方案.
研究的目的:
- 审查CRISPR基因组编辑器与各种纳米载体系统的整合.
- 为了突出纳米载体介导的CRISPR传递的最新进展.
- 讨论治疗性基因组编辑的未来方向.
主要方法:
- 自然和合成纳米载体介导输送系统的探索.
- 对病毒载体,细胞外囊泡 (EV),工程细胞膜颗粒,脂质体和纳米颗粒的分析.
- 专注于载体的效率,特异性和免疫性.
主要成果:
- 纳米载体通过提高效率,特异性和降低免疫性来提高CRISPR的有效性.
- 合成载体为CRISPR传递提供可重复性和可定制功能.
- 病毒载体提供高传导效率,而EV提供免疫逃避和有针对性的传递.
结论:
- 克里斯普尔与纳米载体的结合代表了治疗基因组编辑的重大进步.
- 在基于CRISPR的疗法中,各种纳米载体策略显示出克服交付挑战的前景.
- 对纳米载体系统的进一步研究将推动基因组编辑的临床应用.
相关概念视频
CRISPR
49.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.1K
CRISPR and crRNAs
16.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K


